SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Imclone systems (IMCL)
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
2515 89 0 IMCL
Emcee:  Deeber Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1965Long WSJ account of the IMCL-BMY relationship. #reply-17026200Doc Bones-2/7/2002
1964<<Forget about US trial for the foreseeable future.>> PIII trial isMiljenko Zuanic-2/6/2002
1963<i>Bmy long strategy does not work well for the waksals.</i> ForJdaasoc-2/6/2002
1962Very nice, BMY could sell 100M shares at $10 and get all their money back. They Cacaito-2/6/2002
1961I visited IMCL manufacturing facility today and was impressed about the laxness Jdaasoc-2/6/2002
1960Hangover day 1: I check all the options... Hangover day 2: get out of here sam,Cacaito-2/6/2002
1959The IMCL-BMY Deal - What could have happened: Peter Dolan is negotiating with tDoc Bones-2/6/2002
1958I was close. BMS isn't waiting until bankruptcy to pick up the drug. They 613-2/6/2002
1957BMY today made it public that they are not looking for litigation but rather to IRWIN JAMES FRANKEL-2/5/2002
1956Bristol Will Ditch ImClone Deal Unless Firm Fires Top Executives By MICHAEL WALSaulamanca-2/5/2002
1955Bmy wants the assets, shareholders get the asses !!! BMY wants: 1. wacksals ouCacaito-2/5/2002
1954Tuesday February 5, 6:13 pm Eastern Time Press Release SOURCE: Bristol-Myers SquIRWIN JAMES FRANKEL-2/5/2002
1953All clinical trials are conducted in accord with a protocol developed in conferetelephonics-1/29/2002
1952Motley fool evaluation. (credit some yahoo'er) motleyfool.com613-1/29/2002
1951ImClone Directors Also Were Given Scientific Contracts The Wall Street Journal 613-1/29/2002
1950" How does Avalon know this? " Imcl, either from presentations or leakCacaito-1/28/2002
1949exactly.Casaubon-1/28/2002
1948Protocol was approved by FDA, FAULTY execution by Imcl is the problem and the reCacaito-1/28/2002
1947If so it was protocol approved by FDA.keokalani'nui-1/28/2002
1946I'm sure this is a necessary requirement to enroll in the study.Casaubon-1/28/2002
1945>>David Hines, an analyst with Avalon Research Group in Florida, was unconkeokalani'nui-1/28/2002
1944Maybe Waskel did find them a patsy to sell them their stock...http://biz.yahoo.cArthur Radley-1/28/2002
1943ImClone CEO Under Increasing Scrutiny Biotech: Samuel Waksal runs in celebrity sim1-1/28/2002
1942How a Top Medical Researcher Became Entangled With Enron [NYT] Message 16969997sim1-1/28/2002
1941OT The biweekly schedule study (D1-D15) recommended a dose of 24mg/m^2 during seminole-1/27/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News